NCT07497867 Long-term Prospective Study of Korean CADASIL Patients
| NCT ID | NCT07497867 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Jeju National University Hospital |
| Condition | CADASIL |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2023-07-10 |
| Primary Completion | 2035-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2023-07-10 with a primary completion date of 2035-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
K-CADASIL is a 10-year prospective study of 500 Korean patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), a genetic brain disease that causes stroke and dementia. The investigators will track symptoms, brain scans, memory tests, and gene information to understand disease progression in Koreans and identify better treatments. Participants will visit clinics regularly for check-ups and blood tests. This study aims to help improve care for CADASIL patients and families worldwide.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 19 years * CADASIL suspected or confirmed by genetic testing (NOTCH3 mutation) * Able to provide written informed consent (participant or legally authorized representative) Exclusion Criteria: * Contraindication to MRI (claustrophobia, metal implants, pacemaker) * Acute ischemic or hemorrhagic stroke within 180 days prior to enrollment
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07497867 clinical trial?
This trial is open to participants of all sexes, aged 19 Years or older, studying CADASIL. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07497867 currently recruiting?
Yes, NCT07497867 is actively recruiting participants. Contact the research team at jaychoi@jejunu.ac.kr for enrollment information.
Where is the NCT07497867 trial being conducted?
This trial is being conducted at Jeju City, South Korea.
Who is sponsoring the NCT07497867 clinical trial?
NCT07497867 is sponsored by Jeju National University Hospital. The trial plans to enroll 500 participants.